Comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of acute bacterial sinusitis

Clinical Therapeutics

Volumn 21, Issue 7, 1999, Pages 1158-1170

  Henry, Dan C ^a   Sydnor Jr , Austin ^b   Settipane, Guy A ^c   Allen, James ^d   Burroughs, Scott ^e   Cobb, Margaret M ^e   Holley Jr , H Preston ^e  

^a Foothill Family Clinic   (United States)

^b Virginia Medical Studies Group   (United States)

^c Dip Allergy and Clin Immun Euro   (United States)

^d Southern Research   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

Acute sinusitis; Amoxicillin clavulanate; Cefuroxime axetil

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME AXETIL;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; VAGINITIS;

EID: 0032798230     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80019-3     Document Type: Article

References (23)

1. 1. Gwaltney J. Sinusitis. In: Mandell G, Bennett J, Mandell D, eds. Douglas and Bennett's Principles and Practice of Infectious Disease. New York: John Wiley & Sons, Inc; 1995:585-590.
2. 2. Hadley JA, Schaefer SD. Clinical evaluation of rhinosinusitis - history and physical examination. Otolaryngol Head Neck Surg. 1997;117(Suppl 3):S8-S11.
3. 3. Evans KL. Recognition and management of sinusitis. Drugs. 1998;56:59-71.
4. 4. Wald ER. Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci. 1998;316:13-20.
5. 5. de Ferranti SD, Ioannidis JP, Lau J, et al. Are amoxycillin and folate inhibitors as effective as other antibiotics for acute sinusitis? A meta-analysis. BMJ. 1998;317: 632-637.
6. 6. Doern GV, Brueggemann AB, Pierce G, et al. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:2884-2886.
7. 7. Doern GV, Brueggemann AB, Pierce G, et al. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase - positive strains resistant to amoxicillin-clavulanate: Results of a national multicenter surveillance study. Antimicrob Agents Chemother. 1997;41:292-297.
8. 8. Sudderick RM, Lund VJ, Thomson JP, et al. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue. Rhinology. 1992;30:11-16.
9. 9. Sydnor A Jr, Gwaltney JM Jr, Cocchetto DM, et al. Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg. 1989;115: 1430-1433.
10. 10. Pakes GE, Graham JA, Rauch AM, et al. Cefuroxime axetil in the treatment of sinusitis. A review. Arch Fam Med. 1994;3: 165-175.
11. 11. Ball P, Geddes A, Rolinson G. Amoxycillin clavulanate: An assessment after 15 years of clinical application. J Chemother. 1997;9:167-198.
12. 12. Chow A, Hall C, Klein J, et al. General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis. 1992;15(Suppl 1):S62-S88.
13. 13. Brodie DP, Knight S, Cunningham K. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice. J Int Med Res. 1989;17:547-551.
14. 14. Griffiths GK, VandenBurg MJ, Wight LJ, et al. Efficacy and tolerability of cefuroxime axetil in patients with upper respiratory tract infections. Curr Med Res Opin. 1987;10:555-561.
15. 15. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Drugs Exp Clin Res. 1987;13:91-94.
16. 16. Stefansson P, Jacovides A, Jablonicky P, et al. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. Rhinology. 1998;36:173-178.
17. 17. Wald E. Management of acute bacterial sinusitis in children. In: Johnson J, Lu V, eds. Infectious Diseases and Antimicrobial Therapy in the Ear, Nose and Throat. Philadelphia: W.B. Saunders; 1997:333-339.
18. 18. Kaliner MA. Recurrent sinusitis - examining medical treatment options. Am J Rhinol. 1997;11:123-132.
19. 19. Brankston ER, Conter HS, Corriveau R, et al. Cefprozil versus cefuroxime axetil in the treatment of acute sinusitis. Clin Drug Invest. 1998;15:81-90.
20. 20. Little DR, Mann BL, Sherk DW. Factors influencing the clinical diagnosis of sinusitis. J Fam Pract. 1998;46:147-152.
21. 21. Hueston WJ, Eberlein C, Johnson D, et al. Criteria used by clinicians to differentiate sinusitis from viral upper respiratory tract infection. J Fam Pract. 1998;46:487-492.
22. 22. Fahey T. Applying the results of clinical trials to patients in general practice: Perceived problems, strengths, assumptions, and challenges for the future. Br J Gen Pract. 1998;48:1173-1178.
23. 23. Debock GH, Dekker FW, Stolk J, et al. Antimicrobial treatment in acute maxillary sinusitis - a meta-analysis. J Clin Epidemiol. 1997;50:881-890.